24/02/2011

A review study led by Vall d'Hebron Institute of Research (VHIR) has confirmed the efficacy of methylphenidate for adults with Attention Deficit Disorder with Hyperactivity (ADHD). So far, the European Union authorizes treatment with methylphenidate (a stimulant) for children with Attention Deficit Disorder with Hyperactivity (ADHD), but there are 20 million adults with the same disease and they need treatment, so this study probably will serve to provide enough evidence of the benefits of its use.The reason for this paradox is that studies previously concluded with mixed results regarding the efficacy of methylphenidate in adults. In fact, there had been many studies whose results were very mixed, from the ineffective to a great improvement, but the study by this group of experts from VHIR, not only demonstrates the usefulness of this drug for the treatment in adults with ADHD, but has also identified the factors responsible for this discrepancy of results. And even more refined: the study states the best way of administration of this medication in adults.